VRIJE UNIVERSITEIT BRUSSEL

Their core work

Vrije Universiteit Brussel is a major Belgian research university with deep strengths in AI and machine learning, gene and cell therapy, smart mobility, and responsible innovation. VUB conducts fundamental and applied research across an exceptionally wide range of disciplines — from cosmic ray astrophysics and soft robotics to stem cell therapies and computational social science. Their Brussels location places them at the heart of EU policy-making, which they actively exploit through projects on ethics, fundamental rights, science diplomacy, and public engagement. They bridge hard science and societal impact, making them a versatile partner for both technology-driven and policy-oriented consortia.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2018), VUB focused heavily on fundamental rights, energy efficiency, stem cell research, public engagement, and science communication — reflecting a balance between societal research and biomedical excellence. By 2019–2022, their portfolio shifted markedly toward applied technology: AI intensified (from 3 to 5 keyword hits), while sensors, radar, drones, soft robotics, and additive manufacturing emerged as entirely new themes. This evolution suggests a deliberate move from policy-oriented and fundamental research toward technology integration and physical systems, while maintaining their AI core throughout.

VUB is moving toward applied AI systems with physical-world components (robotics, sensors, drones), making them increasingly relevant for Industry 4.0 and smart infrastructure consortia.

How they like to work

VUB acts as both a capable coordinator (56 of 200 projects, 28%) and a reliable consortium partner, showing versatility in either role. With 2,076 unique partners across 85 countries, they operate as a high-connectivity hub — rarely locked into repeat partnerships, instead forming new alliances per project need. Their Brussels base and policy expertise make them particularly attractive as a "bridge" partner that can link technical workpackages with dissemination, ethics review, and EU institutional engagement.

VUB has collaborated with over 2,000 unique partners across 85 countries, making their network one of the broadest among Belgian universities. Their reach extends well beyond Europe, reflecting both their thematic diversity and their role in global research coordination (e.g., EU-PolarNet trans-Atlantic alliance).

What sets them apart

VUB's rare combination of deep technical research (AI, gene therapy, robotics) with strong expertise in ethics, fundamental rights, and science policy makes them almost uniquely positioned in Belgian academia. Few universities can credibly lead both a EUR 3.4M cell therapy project and a science diplomacy coordination action. For consortium builders, VUB offers a two-for-one: serious technical contribution plus the ability to handle ethics workpackages, responsible innovation assessments, and Brussels-based policy engagement that many projects require but struggle to staff.

Highlights from their portfolio

• BetaCellTherapy
  Largest VUB-coordinated project (EUR 3.4M over 7 years) on stem cell-derived beta cell implants for Type 1 diabetes — demonstrates long-term biomedical leadership.
• LOFAR
  EUR 1.5M ERC-funded project on cosmic ray origins using the LOFAR radio telescope array — showcases VUB's fundamental physics capabilities.
• EL-CSID
  VUB-coordinated project on European science and cultural diplomacy — illustrates their unique policy-research crossover that few technical universities attempt.